Mrv0541 01121511092D 16 15 0 0 0 0 999 V2000 8.3804 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0878 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7952 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.5026 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2100 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.9174 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5965 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3322 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.0396 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.7471 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.4545 -5.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.1619 -5.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6730 -5.7016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.7952 -4.4565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5965 -4.4565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.4545 -4.4565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 13 1 1 0 0 0 0 3 2 1 0 0 0 0 4 3 1 0 0 0 0 14 3 1 0 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 7 6 1 0 0 0 0 8 7 1 0 0 0 0 15 7 1 0 0 0 0 9 8 1 0 0 0 0 10 9 1 0 0 0 0 11 10 1 0 0 0 0 12 11 1 0 0 0 0 16 11 1 0 0 0 0 M END > CHEBI:84239 > 3,7,11-trimethyldodecan-1-ol > A fatty alcohol that is 1-dodecanol substituted by methyl groups at positions 3, 7 and 11. Metabolite observed in cancer metabolism. > 3 > Hexahydrofarnesol > 3,7,11-trimethyldodecan-1-ol > C15H32O > 228.41400 > 228.24532 > 0 > CC(C)CCCC(C)CCCC(C)CCO > InChI=1S/C15H32O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h13-16H,5-12H2,1-4H3 > HDPUXESLSOZSIB-UHFFFAOYSA-N > 6750-34-1 > 1700699 > 6750-34-1 > 25518943 $$$$